Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medication overuse headaches -- what is new?

Guenther Fritsche1, Hans-Christoph Diener

  • 1Department of Neurology, University Essen, Germany. guenther.fritsche@uni-essen.de

Expert Opinion on Drug Safety
|August 9, 2003
PubMed
Summary

Frequent headache sufferers risk medication overuse headache (MOH) from regular pain reliever use. Identifying predictors for overuse and relapse is crucial for better prevention and treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Changes in anticoagulant prescription patterns over time for patients with atrial fibrillation around the world.

Journal of arrhythmia·2021
Same author

MMW Fortschritte der Medizin·2021
Same author

COVID-19 Vaccine-Associated Cerebral Venous Thrombosis in Germany.

Annals of neurology·2021
Same author

Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 months of treatment in the phase 3b FOCUS study.

The journal of headache and pain·2021
Same author

Diagnosis and management of migraine in ten steps.

Nature reviews. Neurology·2021
Same author

Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF study.

European journal of internal medicine·2021

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Frequent headache sufferers, including those with migraines or tension-type headaches, are susceptible to developing medication overuse headache (MOH).
  • MOH is defined by the International Headache Society's classification and results from excessive use of acute headache medications (≥15 days/month).
  • Current standard therapy involves medication withdrawal and prophylactic treatment, but relapse rates can be as high as 40% within a year.

Purpose of the Study:

  • To investigate predictors of medication overuse and relapse in patients with headache.
  • To inform the development of improved prevention and therapeutic strategies for MOH.
  • To highlight the need for structured post-withdrawal programs considering relapse predictors.

Main Methods:

  • Review of existing literature on medication overuse headache.
  • Identification of medical and psychological predictors associated with medication overuse.
  • Analysis of factors contributing to relapse after successful withdrawal therapy.

Main Results:

  • Medication overuse in headache patients is multifactorial, involving physical, social, and psychological elements.
  • Several predictors for medication overuse and relapse have been identified, including the class of overused drugs and psychological factors.
  • The pathophysiology of MOH is not fully understood, leading to experience-based rather than hypothesis-driven treatments.

Conclusions:

  • Understanding predictors of medication overuse and relapse is essential for enhancing prevention and treatment of MOH.
  • A structured post-treatment program is necessary for patients after acute withdrawal, incorporating identified relapse predictors.
  • Further research into MOH pathophysiology is needed to develop more effective, evidence-based therapies.

Related Experiment Videos